tiprankstipranks
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market
8622
Huakang Biomedical Holdings Company Limited
RESEARCH TOOLSreports
Want to see HK:8622 full AI Analyst Report?

Huakang Biomedical Holdings Company Limited (8622) Income Statement

0 Followers

Huakang Biomedical Holdings Company Limited Income Statement

Last quarter (Q2 2025), Huakang Biomedical Holdings Company Limited's total revenue was ¥6.16M, an increase of 3.45% from the same quarter last year. In Q2, Huakang Biomedical Holdings Company Limited's net income was ¥-1.18M. See Huakang Biomedical Holdings Company Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 27.55M¥ 25.36M¥ 24.63M¥ 25.33M¥ 26.13M
Gross Profit
¥ 17.31M¥ 17.07M¥ 16.09M¥ 16.91M¥ 16.46M
Operating Expenses
¥ 25.00M¥ 22.08M¥ 23.48M¥ 22.00M¥ 20.24M
Depreciation and Amortization
¥ 3.62M¥ 1.60M¥ 3.18M¥ 3.14M¥ 2.95M
EBITDA
¥ -4.07M¥ -3.41M¥ -2.55M¥ 188.00K¥ -852.00K
Operating Income
¥ -7.69M¥ -5.01M¥ -7.39M¥ -5.09M¥ -4.58M
Other Income/Expenses
¥ 2.80M¥ 853.00K¥ 1.61M¥ 2.08M¥ 675.00K
Pretax Income
¥ -4.88M¥ -4.16M¥ -5.78M¥ -3.01M¥ -3.90M
Net Income
¥ -4.88M¥ -4.16M¥ -5.78M¥ -3.08M¥ -4.22M
Per Share Metrics
Basic EPS
¥ >-0.01¥ -0.01¥ -0.01¥ -0.01¥ -0.01
Diluted EPS
¥ >-0.01¥ -0.01¥ -0.01¥ -0.01¥ -0.01
Weighted Average Shares Outstanding
 501.44M 482.48M 415.97M 404.64M 400.00M
Weighted Average Shares Outstanding (Diluted)
 501.44M 482.44M 415.96M 404.64M 400.00M
Currency in CNY

Huakang Biomedical Holdings Company Limited Earnings and Revenue History